Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
19.85B | 21.66B | 18.26B | 14.78B | 14.54B | Gross Profit |
14.55B | 13.04B | 12.16B | 12.40B | 11.95B | EBIT |
4.47B | 4.88B | 4.37B | 2.90B | 2.78B | EBITDA |
6.83B | 6.91B | 6.27B | 3.89B | 4.36B | Net Income Common Stockholders |
2.29B | 7.80B | 2.35B | 1.64B | 1.26B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
4.25B | 2.77B | 3.35B | 2.50B | 2.07B | Total Assets |
98.33B | 92.70B | 94.86B | 67.22B | 67.09B | Total Debt |
47.07B | 42.98B | 45.47B | 31.22B | 30.79B | Net Debt |
46.52B | 42.82B | 45.26B | 31.06B | 30.72B | Total Liabilities |
68.43B | 63.13B | 71.00B | 47.36B | 47.51B | Stockholders Equity |
29.87B | 29.54B | 23.83B | 19.84B | 19.56B |
Cash Flow | Free Cash Flow | |||
-514.00M | 6.00M | 728.00M | -327.00M | -282.00M | Operating Cash Flow |
6.94B | 6.90B | 6.27B | 4.46B | 4.62B | Investing Cash Flow |
-7.50B | 240.00M | -14.01B | -5.12B | -3.19B | Financing Cash Flow |
987.00M | -7.17B | 7.77B | 750.00M | -1.61B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | £1.96B | 3.97 | 26.02% | 4.45% | -22.46% | -3.74% | |
71 Outperform | £7.68B | 32.89 | 17.17% | 4.64% | 5.38% | 86.34% | |
71 Outperform | £16.86B | 8.68 | 21.94% | 3.99% | -13.09% | 231.40% | |
67 Neutral | £47.66B | 22.55 | 5.28% | 5.52% | -6.68% | -77.57% | |
65 Neutral | $11.75B | 15.50 | 6.20% | 4.60% | 5.53% | -8.93% | |
64 Neutral | £7.13B | 62.95 | 5.50% | 4.83% | 8.61% | ― | |
53 Neutral | £2.18B | ― | -4.09% | 7.65% | 20.25% | -128.71% |